Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like Endologix Announces Positive Clinical Results From The LEOPARD Clinical Study August 16, 2017 Radius Health's Longtime CEO Out, Former Novo Nordisk A/S Exec Named New Leader July 16, 2017 AbbVie Declares Quarterly Dividend February 19, 2017
